50 results about "Proton density" patented technology

The invention relates to a method of MR imaging of at least a portion of a body of a patient placed in an examination volume of an MR device. The object of the invention is to improve CEST contrast enhanced imaging. The method of the invention comprises the following steps: a) saturation of nuclear magnetization of exchangeable protons of a CEST contrast agent administered to the patient by subjecting the portion of the body to at least one frequency-selective saturation RF pulse matched to the MR frequency of exchangeable protons of the CEST contrast agent, wherein the saturation period, i.e. the duration of the frequency-selective saturation RF pulse, is shorter than the time required for saturation to build up a full CEST contrast enhancement effect when starting from zero saturation; b) generating at least one MR signal of water protons of the body by subjecting the portion of the body to an MR imaging sequence comprising at least one RF pulse and switched magnetic field gradients; c) acquiring and sampling the at least one MR signal from the body; d) repeating steps a) to c) a number of times under variation of parameters of the MR imaging sequence, wherein MR signals are acquired and sampled during a saturation build-up period, i.e. before a steady state of the CEST effect is achieved; e) reconstructing a proton-density weighted, CEST contrast-enhanced MR image from the acquired and sampled MR signals.

An apparatus and method for correcting magnetic resonance temperature measurements is disclosed. In one aspect, the method identifies monitoring regions of interest outside a therapeutic region of interest. Next, a pulse sequence sensitive to changes in T1 and proton density is used to measure the temperature changes in these regions. Next, the PRFS is measured in these same regions. The PRFS in these regions will be caused both by the desired shift from temperature change, and the undesired shift from background magnetic field changes. Using the measured temperature changes from the T1-method, the component of the PRFS due to actual temperature changes is subtracted from the PRFS method, leaving only the component caused by the unwanted magnetic field changes. This analysis is performed separately for each region. At the end of this step, one has measured the change in background magnetic field within each region.

The present invention provides a process for conversion of feedstock comprising organic compounds to desirable conversion product at organic compound conversion conditions in the presence of catalyst comprising an acidic, porous crystalline material and having a Proton Density Index of greater than 1.0, for example, from greater than 1.0 to about 2.0, e.g. from about 1.01 to about 1.85. The acidic, porous crystalline material of the catalyst may comprise a porous, crystalline material or molecular sieve having the structure of zeolite Beta, an MWW structure type material, e.g. MCM-22, MCM-36, MCM-49, MCM-56, or a mixture thereof.

This Invention relates to a method for achieving Focused Resonance Nanopermeabilization (FORN), which can be utilized in a novel anticancer therapy, and other selective permeabilization therapy and a machine to carryout the said method, where the transient permeabilization of cells by Focused Resonance pulses induces a significant increase of anti-tumor drug concentration in tumor or other interested cells. This invention can be successfully applied to the treatment of tumors in humans and Animals by using antimitotic drugs, chemotherapy. The invention is also useful in transpermeabilization of drug molecules for non cancer applications like vaccine and delivery of genetic materials for therapeutic purposes. Focused Resonance Nanopermeabilization (FORN), would enable a practical solution to a whole body application in its natural environment, without implanting electrodes or external probes, FORN is completely non-invasive. This invention also relates to an apparatus for carrying out the above method.